In conclusion, our study is the first to use CRISPR/Cas9 nanocapsules to knockout GDF15 in tumor cells to enhance the immune cell‐mediated killing of tumor cells and promote the tumor‐killing effect of PD1 antibodies. Here, GDF15 is linked to neoplasm.